| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Summary recommendations for standardization and reporting of metabolic analyses.
|
Nat Biotechnol
|
2005
|
2.90
|
|
2
|
Serum metabolomic profiles from patients with acute kidney injury: a pilot study.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2012
|
1.55
|
|
3
|
Structure and dynamics of thioguanine-modified duplex DNA.
|
J Biol Chem
|
2002
|
1.18
|
|
4
|
Monitoring the health to disease continuum with global metabolic profiling and systems biology.
|
Pharmacogenomics
|
2006
|
1.11
|
|
5
|
The utility of a rodent model in detecting pediatric drug-induced nephrotoxicity.
|
Toxicol Sci
|
2007
|
0.97
|
|
6
|
Metabonomics evaluations of age-related changes in the urinary compositions of male Sprague Dawley rats and effects of data normalization methods on statistical and quantitative analysis.
|
BMC Bioinformatics
|
2007
|
0.94
|
|
7
|
Metabonomics evaluation of urine from rats given acute and chronic doses of acetaminophen using NMR and UPLC/MS.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2008
|
0.93
|
|
8
|
The liver toxicity biomarker study: phase I design and preliminary results.
|
Toxicol Pathol
|
2009
|
0.93
|
|
9
|
Targeted liquid chromatography-mass spectrometry analysis of serum acylcarnitines in acetaminophen toxicity in children.
|
Biomark Med
|
2014
|
0.93
|
|
10
|
Metabolomics as an extension of proteomic analysis: study of acute kidney injury.
|
Semin Nephrol
|
2007
|
0.92
|
|
11
|
Variations in metabolism of the soy isoflavonoid daidzein by human intestinal microfloras from different individuals.
|
Arch Microbiol
|
2003
|
0.92
|
|
12
|
Riddelliine N-oxide is a phytochemical and mammalian metabolite with genotoxic activity that is comparable to the parent pyrrolizidine alkaloid riddelliine.
|
Toxicol Lett
|
2003
|
0.92
|
|
13
|
An integrated study of acute effects of valproic acid in the liver using metabonomics, proteomics, and transcriptomics platforms.
|
OMICS
|
2006
|
0.91
|
|
14
|
In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum).
|
J Agric Food Chem
|
2006
|
0.91
|
|
15
|
Gene expression profiles in fathead minnow exposed to 2,4-DNT: correlation with toxicity in mammals.
|
Toxicol Sci
|
2006
|
0.91
|
|
16
|
Isolation of an anaerobic intestinal bacterium capable of cleaving the C-ring of the isoflavonoid daidzein.
|
Arch Microbiol
|
2002
|
0.87
|
|
17
|
CERAPP: Collaborative Estrogen Receptor Activity Prediction Project.
|
Environ Health Perspect
|
2016
|
0.87
|
|
18
|
Metabolomics evaluation of the effects of green tea extract on acetaminophen-induced hepatotoxicity in mice.
|
Food Chem Toxicol
|
2013
|
0.86
|
|
19
|
Differential gene expression in mouse liver associated with the hepatoprotective effect of clofibrate.
|
Toxicol Appl Pharmacol
|
2007
|
0.85
|
|
20
|
Methylation potential associated with diet, genotype, protein, and metabolite levels in the Delta Obesity Vitamin Study.
|
Genes Nutr
|
2014
|
0.84
|
|
21
|
Age-related differences in susceptibility to toxic effects of valproic acid in rats.
|
J Appl Toxicol
|
2008
|
0.84
|
|
22
|
Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo.
|
Cancer Lett
|
2004
|
0.83
|
|
23
|
Identification of metabolite profiles of the catechol-O-methyl transferase inhibitor tolcapone in rat urine using LC/MS-based metabonomics analysis.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2009
|
0.83
|
|
24
|
Assessment of usnic acid toxicity in rat primary hepatocytes using ¹³C isotopomer distribution analysis of lactate, glutamate and glucose.
|
Food Chem Toxicol
|
2011
|
0.82
|
|
25
|
Study of valproic acid-induced endogenous and exogenous metabolite alterations using LC-MS-based metabolomics.
|
Bioanalysis
|
2010
|
0.82
|
|
26
|
Modeling chemical interaction profiles: I. Spectral data-activity relationship and structure-activity relationship models for inhibitors and non-inhibitors of cytochrome P450 CYP3A4 and CYP2D6 isozymes.
|
Molecules
|
2012
|
0.81
|
|
27
|
Studies of acetaminophen and metabolites in urine and their correlations with toxicity using metabolomics.
|
Drug Metab Lett
|
2009
|
0.81
|
|
28
|
Modeling chemical interaction profiles: II. Molecular docking, spectral data-activity relationship, and structure-activity relationship models for potent and weak inhibitors of cytochrome P450 CYP3A4 isozyme.
|
Molecules
|
2012
|
0.81
|
|
29
|
In vitro metabolism of hyperforin in rat liver microsomal systems.
|
Drug Metab Dispos
|
2004
|
0.81
|
|
30
|
¹³C NMR-distance matrix descriptors: optimal abstract 3D space granularity for predicting estrogen binding.
|
J Chem Inf Model
|
2012
|
0.81
|
|
31
|
Partial least square and k-nearest neighbor algorithms for improved 3D quantitative spectral data-activity relationship consensus modeling of acute toxicity.
|
Environ Toxicol Chem
|
2014
|
0.81
|
|
32
|
Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the [U-C(6)]-d-glucose tracer in mice.
|
Metabolomics
|
2009
|
0.80
|
|
33
|
Evaluations of the trans-sulfuration pathway in multiple liver toxicity studies.
|
Toxicol Appl Pharmacol
|
2008
|
0.79
|
|
34
|
Genetic associations with micronutrient levels identified in immune and gastrointestinal networks.
|
Genes Nutr
|
2014
|
0.79
|
|
35
|
Whole-molecule calculation of log p based on molar volume, hydrogen bonds, and simulated 13C NMR spectra.
|
J Chem Inf Model
|
2005
|
0.78
|
|
36
|
Metabolomics evaluation of hydroxyproline as a potential marker of melamine and cyanuric acid nephrotoxicity in male and female Fischer F344 rats.
|
Food Chem Toxicol
|
2012
|
0.78
|
|
37
|
Metabolomics techniques in nanotoxicology studies.
|
Methods Mol Biol
|
2012
|
0.77
|
|
38
|
Evaluating effects of penicillin treatment on the metabolome of rats.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2013
|
0.77
|
|
39
|
Modeling and assaying dioxin-like biological effects for both dioxin-like and certain non-dioxin-like compounds.
|
Toxicol Sci
|
2007
|
0.76
|
|
40
|
Improving proton MR spectroscopy of brain tissue for noninvasive diagnostics.
|
J Magn Reson Imaging
|
2010
|
0.76
|
|
41
|
The role of metabolic biomarkers in drug toxicity studies.
|
Toxicol Mech Methods
|
2008
|
0.76
|
|
42
|
The liver toxicity biomarker study phase I: markers for the effects of tolcapone or entacapone.
|
Toxicol Pathol
|
2012
|
0.75
|
|
43
|
The use of carbon thirteen nuclear magnetic resonance spectra to predict dioxin and furan binding affinities to the aryl hydrocarbon receptor.
|
Environ Toxicol Chem
|
2003
|
0.75
|
|
44
|
Predicting toxic equivalence factors from 13C nuclear magnetic resonance spectra for dioxins, furans, and polychlorinated biphenyls using linear and nonlinear pattern recognition methods.
|
Environ Toxicol Chem
|
2004
|
0.75
|